Relationship between sex and immune checkpoint inhibitors in urothelial carcinoma and renal cell carcinoma

被引：1
|
作者：
Song, Yuxuan [1 ]
Peng, Yun [1 ]
Qin, Caipeng [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Dept Urol, Beijing 100044, Peoples R China
来源：
WORLD JOURNAL OF UROLOGY | 2023年 / 41卷 / 08期
关键词：
CANCER;
D O I：
10.1007/s00345-023-04497-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2301 / 2302
页数：2
相关论文
共 50 条
  • [31] Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma
    Stuhler, Viktoria
    Rausch, Steffen
    Maas, Jan Moritz
    Stenzl, Arnulf
    Bedke, Jens
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1215 - 1226
  • [32] Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
    Jang, Albert
    Lichterman, Jake N.
    Zhong, Jeffrey Y.
    Shoag, Jonathan E.
    Garcia, Jorge A.
    Zhang, Tian
    Barata, Pedro C.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [33] Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma
    Pooja Ghatalia
    Matthew Zibelman
    Daniel M. Geynisman
    Elizabeth R. Plimack
    Current Treatment Options in Oncology, 2017, 18
  • [34] Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma
    Ghatalia, Pooja
    Zibelman, Matthew
    Geynisman, Daniel M.
    Plimack, Elizabeth R.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (01)
  • [35] Immune checkpoint inhibition in urothelial carcinoma
    Szabados, Bernadett
    Powles, Thomas
    LANCET, 2020, 395 (10236): : 1522 - 1523
  • [36] Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Alice Tzeng
    C. Marcela Diaz-Montero
    Patricia A. Rayman
    Jin S. Kim
    Paul G. Pavicic
    James H. Finke
    Pedro C. Barata
    Marcelo Lamenza
    Sarah Devonshire
    Kim Schach
    Hamid Emamekhoo
    Marc S. Ernstoff
    Christopher J. Hoimes
    Brian I. Rini
    Jorge A. Garcia
    Timothy D. Gilligan
    Moshe C. Ornstein
    Petros Grivas
    Targeted Oncology, 2018, 13 : 599 - 609
  • [37] Immune checkpoint blockade in renal cell carcinoma
    Rappold, Phillip M.
    Silagy, Andrew W.
    Kotecha, Ritesh R.
    Hakimi, Ari A.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (03) : 739 - 750
  • [38] Recent advances in immune checkpoint inhibitors in the treatment of urothelial carcinoma: A review
    Kato, Minoru
    Uchida, Junji
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (12) : 1068 - 1077
  • [39] Future Strategies Involving Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Grisay, Guillaume
    Pierrard, Julien
    Confente, Caterina
    Seront, Emmanuel
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (01)
  • [40] Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
    Wang, Di
    Sun, Kai
    Wang, Tianqi
    Zhang, Dongxu
    Sun, Fengze
    Cui, Yuanshan
    Zhao, Hongwei
    Wu, Jitao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345